With 1.41 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.82 million shares. The 52-week range on CDXS shows that it touched its highest point at $6.08 and its lowest point at $2.47 during that stretch. It currently has a 1-year price target of $7.33. Beta for the stock currently stands at 2.37.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CDXS was down-trending over the past week, with a drop of -7.24%, but this was down by -35.47% over a month. Three-month performance dropped to -40.88% while six-month performance fell -0.35%. The stock lost -25.00% in the past year, while it has lost -40.88% so far this year. A look at the trailing 12-month EPS for CDXS yields -0.90 with Next year EPS estimates of -0.56. For the next quarter, that number is -0.24. This implies an EPS growth rate of 17.04% for this year and 23.81% for next year. EPS is expected to grow by 31.19% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -33.31%.
Float and Shares Shorts:
At present, 81.85 million CDXS shares are outstanding with a float of 80.57 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CDXS since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.72159 being high and -$0.91745 being low. For CDXS, this leads to a yearly average estimate of -$0.79375. Based on analyst estimates, the high estimate for the next quarter is -$0.07 and the low estimate is -$0.18. The average estimate for the next quarter is thus -$0.14.
